Therapy-related acute lymphoblastic leukaemia in women with antecedent breast cancer.

Autor: Pourhassan H; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA., Zhang J; Division of Biostatistics, Department of Computational and Quantitative Medicine, City of Hope National Medical Center, Duarte, California, USA., Tinajero J; Pharmacy, City of Hope National Medical Center, Duarte, California, USA., Pullarkat V; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA., Agrawal V; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA., Koller P; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA., Al Malki M; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA., Aribi A; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA., Salhotra A; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA., Sandhu K; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA., Ali H; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA., Stein A; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA., Marcucci G; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA., Forman S; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA., Aldoss I; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA.

Publikováno v: British journal of haematology [Br J Haematol] 2024 Jul; Vol. 205 (1), pp. 158-165. Date of Electronic Publication: 2024 Mar 31.

Thrombopoietin mimetic therapy alleviates radiation-induced bone marrow vascular injury in a bone marrow transplant mouse model.

Autor: Ghimire H; Department of Radiation Oncology, City of Hope National Medical Center, Duarte, CA, United States., Sargur Madabushi S; Department of Radiation Oncology, City of Hope National Medical Center, Duarte, CA, United States., Vercellino J; Department of Radiation Oncology, Montefiore Medical Center, Bronx, NY, United States.; Department of Pathology, Albert Einstein College of Medicine, Bronx, NY, United States., Brooks J; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, United States., Zuro D; Department of Radiation Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States., Lim JE; Department of Radiation Oncology, City of Hope National Medical Center, Duarte, CA, United States., Vishwasrao P; Department of Radiation Oncology, City of Hope National Medical Center, Duarte, CA, United States., Abdelhamid AMH; Department of Radiation Oncology, City of Hope National Medical Center, Duarte, CA, United States.; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt., Strome G; Department of Radiotherapy, Universitair Ziekenhuis (UZ) Brussels, Brussels, Belgium., Eichenbaum G; Johnson and Johnson, Office of the Chief Medical Officer, New Brunswick, NJ, United States., Al Malki M; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, United States., Guha C; Department of Radiation Oncology, Montefiore Medical Center, Bronx, NY, United States.; Department of Pathology, Albert Einstein College of Medicine, Bronx, NY, United States., Hui SK; Department of Radiation Oncology, City of Hope National Medical Center, Duarte, CA, United States.

Publikováno v: Frontiers in oncology [Front Oncol] 2024 Oct 10; Vol. 14, pp. 1414488. Date of Electronic Publication: 2024 Oct 10 (Print Publication: 2024).

Impact of Antifungal Prophylaxis Continuation or Discontinuation After Allogeneic Hematopoietic Cell Transplant on the Incidence of Invasive Mold Infection.

Autor: Ross JA; Department of Pharmacy, City of Hope National Medical Center, Duarte, California, USA., Lee B; Department of Pharmacy, City of Hope National Medical Center, Duarte, California, USA., Ma H; Division of Biostatistics, Department of Computational and Quantitative Medicine, Beckman Research Institute of City of Hope, Duarte, California, USA., Tegtmeier B; Department of Quality Risk and Regulatory Management, City of Hope National Medical Center, Duarte, California, USA., Nanayakkara D; Division of Infectious Disease, City of Hope National Medical Center, Duarte, California, USA., Dickter J; Division of Infectious Disease, City of Hope National Medical Center, Duarte, California, USA., Spielberger R; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA., Smith E; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA., Pullarkat V; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA., Forman SJ; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA., Taplitz R; Department of Medicine, City of Hope National Medical Center, Duarte, California, USA., Nakamura R; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA., Al Malki M; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA., Dadwal SS; Division of Infectious Disease, City of Hope National Medical Center, Duarte, California, USA.

Publikováno v: Open forum infectious diseases [Open Forum Infect Dis] 2024 Jul 23; Vol. 11 (8), pp. ofae409. Date of Electronic Publication: 2024 Jul 23 (Print Publication: 2024).

Scattering polarization due to light source anisotropy

Autor: Ignace, R, Al-Malki, M, Simmons, J, Brown, J C, Clarke, D, Carson, J

We consider the polarization arising from scattering in an envelope illuminated by a central anisotropic source. Spherical harmonics are used to describe both the light source anisotropy and the envelope density distribution functions of the scatteri

Externí odkaz: http://arxiv.org/abs/0812.2772

Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD.

Autor: Etra A; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., El Jurdi N; Hematology, Oncology and Transplant, University of Minnesota, Minneapolis, MN., Katsivelos N; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Kwon D; Department of Population Health Science and Policy, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Gergoudis S; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Morales G; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Spyrou N; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Kowalyk S; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Aguayo-Hiraldo P; Division of Hematology, Oncology, and Blood and Marrow Transplantation, Children's Hospital Los Angeles, Los Angeles, CA., Akahoshi Y; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Ayuk F; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Baez J; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Betts BC; Hematology, Oncology and Transplant, University of Minnesota, Minneapolis, MN., Chanswangphuwana C; Blood and Marrow Transplantation Program, Chulalongkorn University, Bangkok, Thailand., Chen YB; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA., Choe H; Division of Hematology, James Cancer Center, The Ohio State University, Columbus, OH., DeFilipp Z; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA., Gleich S; Department of Hematology and Oncology, Internal Medicine III, University of Regensburg, Regensburg, Germany., Hexner E; Blood and Marrow Transplantation Program, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA., Hogan WJ; Division of Hematology, Mayo Clinic, Rochester, MN., Holler E; Department of Hematology and Oncology, Internal Medicine III, University of Regensburg, Regensburg, Germany., Kitko CL; Pediatric Stem Cell Transplant Program, Vanderbilt University Medical Center, Nashville, TN., Kraus S; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany., Al Malki M; Hematology/Hematopoietic Cell Transplant, City of Hope National Medical Center, Duarte, CA., MacMillan M; Hematology, Oncology and Transplant, University of Minnesota, Minneapolis, MN., Pawarode A; Blood and Marrow Transplantation Program, University of Michigan, Ann Arbor, MI., Quagliarella F; Ospedale Bambino Gesu', Rome, Italy., Qayed M; Aflac Cancer and Blood Disorders Center, Emory University, Atlanta, GA., Reshef R; Blood and Marrow Transplantation Program, Columbia University Medical Center, New York, NY., Schechter T; Division of Hematology/Oncology/BMT, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada., Vasova I; Med. Klinik III/Poliklinik, Universitatsklinik Erlangen, Erlangen, Germany., Weisdorf D; Hematology, Oncology and Transplant, University of Minnesota, Minneapolis, MN., Wölfl M; Pediatric Blood and Marrow Transplantation Program, Children's Hospital, University of Würzburg, Würzburg, Germany., Young R; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Nakamura R; Hematology/Hematopoietic Cell Transplant, City of Hope National Medical Center, Duarte, CA., Ferrara JLM; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Levine JE; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Holtan S; Hematology, Oncology and Transplant, University of Minnesota, Minneapolis, MN.

Publikováno v: Blood advances [Blood Adv] 2024 Jun 25; Vol. 8 (12), pp. 3284-3292.